Markets:

Overview

News

Currencies

International

Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

60.23 +1.81 (+3.10%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

43 44 Next >

Why Wall Street Got Even More Excited About The Glucose Monitor — And How Dexcom, Abbott Labs Stand To Benefit ↗

April 12, 2024

Continuous glucose monitors have spiked in popularity since the advent of weight-loss drugs. Is chronic disease at its end?

Via Investor's Business Daily

Why NASDAQ:DXCM Is a Promising High-Growth Stock in the Midst of Consolidation. ↗

April 11, 2024

Via Chartmill

Nasdaq Nightmares: 3 Stocks to Sell Before Reality Sets In ↗

April 10, 2024

DoorDash, DexCom, and Advanced Micro Devices are three Nasdaq stocks to sell before reality sets in as exuberance may be fading.

Via InvestorPlace

3 Obesity Drug Stocks Set to Skyrocket as Demand Goes Wild ↗

April 10, 2024

Discover top obesity drug stocks set to soar as demand surges. Eli Lilly, Novo Nordisk, & Dexcom lead with revolutionary treatments

Via InvestorPlace

The Analyst Verdict: DexCom In The Eyes Of 4 Experts ↗

April 10, 2024

Via Benzinga

DexCom Stock Sees IBD Stock Market Rating Sweetens Ups; Earns 83 RS Rating ↗

April 08, 2024

The Relative Strength (RS) Rating for DexCom stock entered a new percentile Monday, with a rise from 80 to 83.

Via Investor's Business Daily

DexCom Inc Chart Analysis ↗

March 26, 2024

Technical analysis of the stock chart for DXCM.

Via Talk Markets

Here's How Much $1000 Invested In DexCom 15 Years Ago Would Be Worth Today ↗

March 25, 2024

Via Benzinga

NASDAQ:DXCM—Positioned as a High-Growth Stock, Ready for a Potential Breakout. ↗

March 21, 2024

DEXCOM INC (NASDAQ:DXCM) qualifies as a high growth stock and is consolidating.

Via Chartmill

2 Growth Stocks to Buy Hand Over Fist in April ↗

April 08, 2024

These healthcare companies' target markets substantially overlap.

Via The Motley Fool

7 Nasdaq Stocks to Sell in April Before They Crash & Burn ↗

April 03, 2024

The momentum in growth companies is likely to run out. Move on from these Nasdaq stocks to sell in April before it's too late.

Via InvestorPlace

Dexcom Publishes Annual Sustainability Report

April 03, 2024

From DexCom, Inc.

Via Business Wire

Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time

April 02, 2024

From DexCom, Inc.

Via Business Wire

DexCom's Options: A Look at What the Big Money is Thinking ↗

March 20, 2024

Via Benzinga

Here's How Much You Would Have Made Owning DexCom Stock In The Last 15 Years ↗

March 14, 2024

Via Benzinga

DexCom Stock Gains from GLP-1 Diabetic Users

April 02, 2024

DexCom Inc. (NASDAQ: DXCM) is a leading medical device company in the medical sector that specializes in continuous glucose monitoring (CGM) systems. People

Via MarketBeat

3 Overvalued S&P 500 Stocks for Your ‘Do NOT Buy’ List ↗

April 01, 2024

The S&P 500’s current P/E ratio is 30% higher than a year ago, making it easier to find overvalued S&P 500 stocks to buy.

Via InvestorPlace

Topics Stocks

Micron, Dropbox And 2 Other Stocks Insiders Are Selling ↗

April 01, 2024

The Nasdaq 100 closed lower by around 0.1% on Thursday. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

Market Cap Game Show: Andy Cross vs. Bill Mann ↗

March 30, 2024

Join the "Rule Breaker Investing" fun.

Via The Motley Fool

Analyst Expectations For DexCom's Future ↗

March 12, 2024

Via Benzinga

Dexcom Stock Shows Market Leadership, Gets Rating Upgrade. Prognosis Good. ↗

March 26, 2024

Among its other key ratings Dexcom has a near-best 98 Earnings Per Share Rating out of 99, reflecting strong profit growth this past year.

Via Investor's Business Daily

Two Hot AI Stocks Lead S&P 500 Monday ↗

March 25, 2024

Super Micro and Micron , two big winners in 2024, led the way Monday.

Via Investor's Business Daily

Topics Artificial Intelligence Stocks

More Than 86% of Analysts Who Cover These 3 Stocks Rate Them a ‘Buy’ ↗

March 25, 2024

Investors should take notice of these stocks with high analyst ratings. It's time to load up your portfolio.

Via InvestorPlace

S&P 500 Giants Lead Five Stocks Near Buy Points With Fed's Powell A Tailwind ↗

March 23, 2024

DexCom, Blackstone and Royal Caribbean head this list of five stocks.

Via Investor's Business Daily

Topics Economy Stocks

Edwards Lifesciences Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark ↗

March 19, 2024

The Relative Strength (RS) Rating for Edwards Lifesciences stock jumped into a new percentile Tuesday, with a rise from 78 to 81.

Via Investor's Business Daily

DexCom Stock Trying To Close In On Key Technical Benchmark ↗

March 18, 2024

In a welcome move, medical device DexCom stock saw its Relative Strength Rating improve from 68 to 73 on Monday.

Via Investor's Business Daily

10 Health Care Stocks Whale Activity In Today's Session ↗

March 18, 2024

Via Benzinga

DexCom Is 'Expanding Rapidly' With Multi-Year Runway Ahead, Bullish Analyst Says ↗

March 12, 2024

DexCom Inc’s (NASDAQ: DXCM) Stelo Glucose Biosensor System has been approved by the Food and Drug Administration (FDA) as the first over-the-counter (OTC)

Via Benzinga

Tandem Diabetes Care Stock Belongs On Your Watchlist As RS Rating Jump Higher ↗

March 11, 2024

On Monday, Tandem Diabetes Care stock received an upgrade to its Relative Strength (RS) Rating, from 68 to 78.

Via Investor's Business Daily

ServiceNow Setting Up As Three Stocks Flash Buy Signals ↗

March 09, 2024

All four stocks to watch boast solid earnings growth.

Via Investor's Business Daily

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

43 44 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

DexCom, Inc. - Common Stock (NQ:DXCM)

All News about DexCom, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today